seed
Stage
2016
Founded
2
Investors
About
Cryonove Pharma is a French biotech company developing innovative therapies for rare diseases. Their focus is on neurodegenerative disorders, with a lead program targeting Amyotrophic Lateral Sclerosis (ALS).
Explore Cryonove Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.